Latest Moderna News

From immunotherapy to mRNA vaccines – the latest science on melanoma treatment explained
‘Cloaked’ proteins deliver cancer-killing therapeutics into cells
Labor fails promise on 100 million mRNA vaccines by 2024
Too many Australians aren’t getting a flu vaccine. Why, and what can we do about it?
AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation
Anticipating the inevitable: how prepared are we for the next pandemic?
Australian Prime Minister Radio interview – 3AW Mornings
Monash Technology Precinct recognised as exemplary global innovation district
Australian Prime Minister Radio interview – 2SM The John Laws Morning Show
Constitutional complaint brought against Federal Court Judge for concealing pharma connections
Applications open for Moderna’s 2024 Australia Fellowship Program
Vaccine shows promise against CMV, a virus that causes birth defects
Investing In World-First Tech For Vaccine Development
An RSV vaccine has been approved for people over 60. But what about young children?
Boosting Pandemic Preparedness With Research Grants
New COVID vaccine in pharmacies from today
AusBiotech weighs in on Australia’s RNA future
New Covid vaccines available to target current variants
ATAGI recommendations on use of the Moderna and Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccines
Backing The Next Generation Of mRNA Drug Discovery – And Jobs
New milestone for Moderna vaccine facility
Moderna marks half-way point in construction of mRNA manufacturing facility
New Milestone For Moderna Vaccine Facility
Covid vaccine safety report – 24-08-2023
Understanding Australia’s RNA potential
Moderna launches regional research centre and headquarters to advance mRNA research
Women’s health specialist receives MTPConnect REDI fellowship with MODERNA Australia
A major day for Moderna as the company builds its Australian presence
Monash University and Moderna form partnership to advance homegrown mRNA medicines
Moderna’s New Centre To Accelerate mRNA Research
The WHO has declared Eris a ‘variant of interest’. How is it different from other Omicron variants?
Covid vaccine safety report – 10-08-2023
Unapproved GMOs in Pfizer and Moderna mRNA Covid-19 vaccines, court case alleges
Covid vaccine safety report – 27-07-2023
Bringing new science to market
Moderna submits RSV vaccine to global regulatory agencies
Covid vaccine safety report – 29-06-2023
MRNA Cancer Treatments One Step Closer
Covid vaccine safety report – 15-06-2023
Product Information safety updates – April and May 2023
Covid vaccine safety report – 01-06-2023
ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older
Covid vaccine weekly safety report – 18-05-2023
Covid vaccine safety report – 04-05-23
Victoria And South Africa To Partner On mRNA Vaccines
Moderna’s COVID-19 vaccine SPIKEVAX receives approval for full registration
Covid vaccine safety report – 20-04-23
Wonder drug-capsule may one day replace insulin injection for diabetics